Artiva Biotherapeutics, Inc.
ARTV
$11.78
$0.564.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.65% | -12.17% | -13.62% | -14.22% | -10.50% |
| Total Receivables | -21.77% | -12.74% | -14.66% | 340.17% | -77.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -65.10% | -31.46% | 0.11% | 48.96% | 76.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.24% | -13.02% | -13.11% | -12.32% | -9.87% |
|
|
|||||
| Total Current Assets | -21.24% | -13.02% | -13.11% | -12.32% | -9.87% |
| Net Property, Plant & Equipment | -6.10% | -5.98% | -6.89% | -4.61% | 1.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 4.55% | 76.15% | 5.27% | -9.71% |
| Total Assets | -19.08% | -12.04% | -12.12% | -11.44% | -8.74% |
|
|
|||||
| Total Accounts Payable | 543.94% | -58.14% | -30.21% | -40.32% | 81.62% |
| Total Accrued Expenses | -42.09% | 36.64% | 20.35% | -8.42% | -13.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.78% | -3.56% | -12.90% | -2.10% | -0.53% |
| Total Finance Division Other Current Liabilities | -- | 0.00% | 0.00% | 0.00% | -- |
| Total Other Current Liabilities | -- | 0.00% | 0.00% | 0.00% | -- |
| Total Current Liabilities | -16.86% | 17.70% | 3.26% | -11.77% | -0.40% |
|
|
|||||
| Total Current Liabilities | -16.86% | 17.70% | 3.26% | -11.77% | -0.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.31% | -7.47% | -11.09% | -6.75% | -3.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -13.65% | 6.78% | -3.50% | -9.48% | -2.01% |
|
|
|||||
| Common Stock & APIC | 0.34% | 0.34% | 0.37% | 0.35% | 0.54% |
| Retained Earnings | -7.11% | -6.71% | -7.47% | -7.96% | -8.23% |
| Treasury Stock & Other | -117.48% | 18.39% | 4,250.00% | -- | -- |
| Total Common Equity | -20.12% | -14.90% | -13.30% | -11.70% | -9.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.12% | -14.90% | -13.30% | -11.70% | -9.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.12% | -14.90% | -13.30% | -11.70% | -9.57% |
|
|
|||||